GRAIL and Epic Partner to Integrate Multi-Cancer Early Detection Test into EHR
The collaboration allows clinicians to order the Galleri test and view results directly within existing electronic health record workflows.
Read MorePosted by CLP Edit Staff | Apr 8, 2026 | Company News |
The collaboration allows clinicians to order the Galleri test and view results directly within existing electronic health record workflows.
Read MorePosted by CLP Edit Staff | Apr 7, 2026 | Allergy & Autoimmune |
The collaboration focuses on advancing proprietary biomarkers for the earlier and more accurate detection of the autoimmune disease.
Read MorePosted by CLP Edit Staff | Apr 7, 2026 | Company News |
The AMA has approved a new PLA CPT code, effective July 1, 2026, to support claims processing and clinical adoption in CNS metastases diagnostics.
Read MorePosted by CLP Edit Staff | Apr 7, 2026 | Cancer |
20/20 BioLabs’ AI-powered multi-cancer early detection test, OneTest for Cancer, is now available to approximately 40,000 clinicians via the Evexia Diagnostics platform.
Read MorePosted by CLP Edit Staff | Apr 7, 2026 | Cancer, Lung Cancer, Molecular Diagnostics |
Biodesix will present seven abstracts—including two oral sessions—at AACR 2026, highlighting advances in automated myeloid testing, liquid biopsy, and NGS-based cancer monitoring platforms.
Read More